相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reduced ex vivo susceptibility of Plasmodium falciparum after oral artemether-lumefantrine treatment in Mali
Souleymane Dama et al.
MALARIA JOURNAL (2017)
Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015
Mateusz M. Plucinski et al.
MALARIA JOURNAL (2017)
Mefloquine targets the Plasmodium falciparum 80S ribosome to inhibit protein synthesis
Wilson Wong et al.
NATURE MICROBIOLOGY (2017)
Population Structure Shapes Copy Number Variation in Malaria Parasites
Ian H. Cheeseman et al.
MOLECULAR BIOLOGY AND EVOLUTION (2016)
Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda
Fredrick Kateera et al.
ACTA TROPICA (2016)
Artemisinin-A Gift from Traditional Chinese Medicine to the World (Nobel Lecture)
Youyou Tu
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine in Ugandan Schoolchildren Selects for Plasmodium falciparum Transporter Polymorphisms That Modify Drug Sensitivity
Joaniter I. Nankabirwa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Artemisinin Resistance and the Blame Game
Sanjeev Krishna et al.
CLINICAL INFECTIOUS DISEASES (2016)
The Importance of Scientific Debate in the Identification, Containment, and Control of Artemisinin Resistance Reply
Aung Pyae Phyo et al.
CLINICAL INFECTIOUS DISEASES (2016)
Artemisinin Resistance in Southeast Asia
Steve Meshnick
CLINICAL INFECTIOUS DISEASES (2016)
The Importance of Scientific Debate in the Identification, Containment, and Control of Artemisinin Resistance
Ian M. Hastings et al.
CLINICAL INFECTIOUS DISEASES (2016)
Role of K13 Mutations in Artemisinin-Based Combination Therapy
Charlotte Rasmussen et al.
CLINICAL INFECTIOUS DISEASES (2016)
Declining Efficacy of Artemisinin Combination Therapy Against P. Falciparum Malaria on the Thai-Myanmar Border (2003-2013): The Role of Parasite Genetic Factors
Aung Pyae Phyo et al.
CLINICAL INFECTIOUS DISEASES (2016)
Can new treatment developments combat resistance in malaria?
Nicholas J. White
EXPERT OPINION ON PHARMACOTHERAPY (2016)
Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial
Issaka Sagara et al.
LANCET INFECTIOUS DISEASES (2016)
In vitro selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemisinin
Muturi J. Njokah et al.
MALARIA JOURNAL (2016)
CRISPR-Cas9-modified pfmdr1 protects Plasmodium falciparum asexual blood stages and gametocytes against a class of piperazine-containing compounds but potentiates artemisinin-based combination therapy partner drugs
Caroline L. Ng et al.
MOLECULAR MICROBIOLOGY (2016)
The Plasmodium falciparum chloroquine resistance transporter is associated with the ex vivo P. falciparum African parasite response to pyronaridine
Marylin Madamet et al.
PARASITES & VECTORS (2016)
Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies
M. Isabel Veiga et al.
NATURE COMMUNICATIONS (2016)
Intramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled Trial
Peter G. Kremsner et al.
PLOS MEDICINE (2016)
Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso
Paul Sondo et al.
PLOS ONE (2016)
Quantifying the pharmacology of antimalarial drug combination therapy
Ian M. Hastings et al.
SCIENTIFIC REPORTS (2016)
Reply to No Robust Evidence of Lumefantrine Resistance
Mateusz M. Plucinski et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
How Robust Are Malaria Parasite Clearance Rates as Indicators of Drug Effectiveness and Resistance?
Ian M. Hastings et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance
Suwanna Chaorattanakawee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Decreasing pfmdr1 Copy Number Suggests that Plasmodium falciparum in Western Cambodia Is Regaining In Vitro Susceptibility to Mefloquine
Pharath Lim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola
Kinanga Kiaco et al.
MALARIA JOURNAL (2015)
Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine
Aurelie Pascual et al.
MALARIA JOURNAL (2015)
Analysis of Major Genome Loci Underlying Artemisinin Resistance and pfmdr1 Copy Number in pre- and post-ACTs in Western Kenya
Bidii S. Ngalah et al.
SCIENTIFIC REPORTS (2015)
Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya
Angela O. Achieng et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2015)
Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Malaria in Children in Zaire and Uige Provinces, Angola
Mateusz M. Plucinski et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
In Vivo Selection of Plasmodium falciparum Pfcrt and Pfmdr1 Variants by Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine in Burkina Faso
Vito Baraka et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Genetic polymorphisms of candidate markers and in vitro susceptibility of Plasmodium falciparum isolates from Thai-Myanmar border in relation to clinical response to artesunate-mefloquine combination
Papichaya Phompradit et al.
ACTA TROPICA (2014)
Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors that Affect Treatment Outcomes for P-falciparum Malaria after Artemether-Lumefantrine and Artesunate-Amodiaquine
Meera Venkatesan et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2014)
Temporal Changes in Prevalence of Molecular Markers Mediating Antimalarial Drug Resistance in a High Malaria Transmission Setting in Uganda
George W. Mbogo et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2014)
Plasmodium falciparum Polymorphisms Associated with Ex Vivo Drug Susceptibility and Clinical Effectiveness of Artemisinin-Based Combination Therapies in Benin
Sabina Dahlstroem et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Selection of Drug Resistance-Mediating Plasmodium falciparum Genetic Polymorphisms by Seasonal Malaria Chemoprevention in Burkina Faso
Anyirekun Fabrice Some et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Ex Vivo Activity of Endoperoxide Antimalarials, Including Artemisone and Arterolane, against Multidrug-Resistant Plasmodium falciparum Isolates from Cambodia
Charlotte A. Lanteri et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Role of Pfmdr1 in In Vitro Plasmodium falciparum Susceptibility to Chloroquine, Quinine, Monodesethylamodiaquine, Mefloquine, Lumefantrine, and Dihydroartemisinin
Nathalie Wurtz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Prevalence of pfmdr1 alleles associated with artemether-lumefantrine tolerance/resistance in Maputo before and after the implementation of artemisinin-based combination therapy
Elsa Lobo et al.
MALARIA JOURNAL (2014)
Four years' monitoring of in vitro sensitivity and candidate molecular markers of resistance of Plasmodium falciparum to artesunate-mefloquine combination in the Thai-Myanmar border
Papichaya Phompradit et al.
MALARIA JOURNAL (2014)
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Frederic Ariey et al.
NATURE (2014)
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
E. A. Ashley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Rapid Selection of Plasmodium falciparum Chloroquine Resistance Transporter Gene and Multidrug Resistance Gene-1 Haplotypes Associated with Past Chloroquine and Present Artemether-Lumefantrine Use in Inhambane District, Southern Mozambique
Thomas T. Thomsen et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2013)
Mefloquine Exposure Induces Cell Cycle Delay and Reveals Stage-Specific Expression of the pfmdr1 Gene
Elaine B. Bohorquez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Assessing the Cost-Benefit Effect of a Plasmodium falciparum Drug Resistance Mutation on Parasite Growth In Vitro
Gabrielle Froberg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Fitness Consequences of Plasmodium falciparum pfmdr1 Polymorphisms Inferred from Ex Vivo Culture of Ugandan Parasites
Edwin Ochong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
In Vitro Sensitivities of Plasmodium falciparum Isolates from the China-Myanmar Border to Piperaquine and Association with Polymorphisms in Candidate Genes
Mingming Hao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Ex Vivo Susceptibility of Plasmodium falciparum to Antimalarial Drugs in Western, Northern, and Eastern Cambodia, 2011-2012: Association with Molecular Markers
Pharath Lim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
UV-triggered Affinity Capture Identifies Interactions between the Plasmodium falciparum Multidrug Resistance Protein 1 (PfMDR1) and Antimalarial Agents in Live Parasitized Cells
Ralf Brunner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Plasmodium falciparum Drug Resistance Phenotype as Assessed by Patient Antimalarial Drug Levels and Its Association With pfmdr1 Polymorphisms
Maja Malmberg et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania
Maja Malmberg et al.
MALARIA JOURNAL (2013)
Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity, clonality and drug resistance markers
Donelly A. van Schalkwyk et al.
MALARIA JOURNAL (2013)
Identification of resistance of Plasmodium falciparum to artesunate-mefloquine combination in an area along the Thai-Myanmar border: integration of clinico-parasitological response, systemic drug exposure, and in vitro parasite sensitivity
Kesara Na-Bangchang et al.
MALARIA JOURNAL (2013)
Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy
Nancy O. Duah et al.
MALARIA JOURNAL (2013)
The Role of Pfmdr1 and Pfcrt in Changing Chloroquine, Amodiaquine, Mefloquine and Lumefantrine Susceptibility in Western-Kenya P. falciparum Samples during 2008-2011
Fredrick L. Eyase et al.
PLOS ONE (2013)
Antidogmatic approaches to artemisinin resistance: reappraisal as treatment failure with artemisinin combination therapy
Sanjeev Krishna et al.
TRENDS IN PARASITOLOGY (2013)
Artemisinin resistance in Plasmodium falciparum: what is it really?
Pedro Eduardo Ferreira et al.
TRENDS IN PARASITOLOGY (2013)
Increased pfmdr1 copy number in Plasmodium falciparum isolates from Suriname
Mergiory Labadie-Bracho et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2013)
Plasmodium falciparum with Multidrug Resistance 1 Gene Duplications, Senegal
Aurelie Pascual et al.
EMERGING INFECTIOUS DISEASES (2013)
pfmdr1 Amplification Is Related to Increased Plasmodium falciparum In Vitro Sensitivity to the Bisquinoline Piperaquine
M. I. Veiga et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Discordant Temporal Evolution of Pfcrt and Pfmdr1 Genotypes and Plasmodium falciparum In Vitro Drug Susceptibility to 4-Aminoquinolines after Drug Policy Change in French Guiana
Eric Legrand et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Dihydroartemisinin/Piperaquine A Review of its Use in the Treatment of Uncomplicated Plasmodium falciparum Malaria
Gillian M. Keating
DRUGS (2012)
Coartem®: a decade of patient-centric malaria management
Kamal Hamed et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2012)
In Vitro-Reduced Susceptibility to Artemether in P. falciparum and Its Association With Polymorphisms on Transporter Genes
Carolina Bustamante et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Mechanisms of in vitro resistance to dihydroartemisinin in Plasmodium falciparum
Long Cui et al.
MOLECULAR MICROBIOLOGY (2012)
Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal
Nathalie Wurtz et al.
MALARIA JOURNAL (2012)
Artemether resistance in vitro is linked to mutations in PfATP6 that also interact with mutations in PfMDR1 in travellers returning with Plasmodium falciparum infections
Dylan R. Pillai et al.
MALARIA JOURNAL (2012)
From methylene blue to chloroquine: a brief review of the development of an antimalarial therapy
Kristine Krafts et al.
PARASITOLOGY RESEARCH (2012)
Molecular analysis of pfatp6 and pfmdr1 polymorphisms and their association with in vitro sensitivity in Plasmodium falciparum isolates from the Thai-Myanmar border
Papichaya Phompradit et al.
ACTA TROPICA (2011)
Antimalarial Drug Sensitivity Profile of Western Kenya Plasmodium falciparum Field Isolates Determined by a SYBR Green I in vitro Assay and Molecular Analysis
Hoseah M. Akala et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
Molecular Assessment of Plasmodium falciparum Resistance to Antimalarial Drugs in Papua New Guinea Using an Extended Ligase Detection Reaction Fluorescent Microsphere Assay
Rina P. M. Wong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Increased pfmdr1 Copy Number and Sequence Polymorphisms in Plasmodium falciparum Isolates from Sudanese Malaria Patients Treated with Artemether-Lumefantrine
Nahla B. Gadalla et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Piperaquine Resistance Is Associated with a Copy Number Variation on Chromosome 5 in Drug-Pressured Plasmodium falciparum Parasites
Richard T. Eastman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Efficacy and Effectiveness of Artemether-Lumefantrine after Initial and Repeated Treatment in Children < 5 Years of Age with Acute Uncomplicated Plasmodium falciparum Malaria in Rural Tanzania: A Randomized Trial
Billy E. Ngasala et al.
CLINICAL INFECTIOUS DISEASES (2011)
Global gene expression profiling of Plasmodium falciparum in response to the anti-malarial drug pyronaridine
Kanyanan Kritsiriwuthinan et al.
MALARIA JOURNAL (2011)
Novel Polymorphisms in Plasmodium falciparum ABC Transporter Genes Are Associated with Major ACT Antimalarial Drug Resistance
Maria Isabel Veiga et al.
PLOS ONE (2011)
PfMDR1: Mechanisms of Transport Modulation by Functional Polymorphisms
Pedro Eduardo Ferreira et al.
PLOS ONE (2011)
Declining Responsiveness of Plasmodium falciparum Infections to Artemisinin-Based Combination Treatments on the Kenyan Coast
Steffen Borrmann et al.
PLOS ONE (2011)
Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate
Wanna Chaijaroenkul et al.
ACTA TROPICA (2010)
Association Between the pfmdr1 Gene and In Vitro Artemether and Lumefantrine Sensitivity in Thai Isolates of Plasmodium falciparum
Mathirut Mungthin et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2010)
Absence of Association between Piperaquine In Vitro Responses and Polymorphisms in the pfcrt, pfmdr1, pfmrp, and pfnhe Genes in Plasmodium falciparum
Sebastien Briolant et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Exploring the Contribution of Candidate Genes to Artemisinin Resistance in Plasmodium falciparum
Mallika Imwong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Amodiaquine Resistance in Plasmodium falciparum Malaria in Afghanistan Is Associated with the pfcrt SVMNT Allele at Codons 72 to 76
Khalid Beshir et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Selection of Known Plasmodium falciparum Resistance-Mediating Polymorphisms by Artemether-Lumefantrine and Amodiaquine Sulfadoxine-Pyrimethamine but Not Dihydroartemisinin-Piperaquine in Burkina Faso
Anyirekun Fabrice Some et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Plasmodium falciparum Isolates with Increased pfmdr1 Copy Number Circulate in West Africa
Benoit Witkowski et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
pfmdr1 Amplification and Fixation of pfcrt Chloroquine Resistance Alleles in Plasmodium falciparum in Venezuela
Sean Griffing et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Artemisinin Resistance in Cambodia: A Clinical Trial Designed to Address an Emerging Problem in Southeast Asia
Harald Noedl et al.
CLINICAL INFECTIOUS DISEASES (2010)
Quinolines and structurally related heterocycles as antimalarials
Kirandeep Kaur et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
pfmdr1 Amplification Associated with Clinical Resistance to Mefloquine in West Africa: Implications for Efficacy of Artemisinin Combination Therapies
Benoit Witkowski et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Multiple Genetic Backgrounds of the Amplified Plasmodium falciparum Multidrug Resistance (pfmdr1) Gene and Selective Sweep of 184F Mutation in Cambodia
Sumiti Vinayak et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Protecting the malaria drug arsenal: halting the rise and spread of amodiaquine resistance by monitoring the PfCRT SVMNT type
Juliana M. Sa et al.
MALARIA JOURNAL (2010)
Antimalarial Exposure Delays Plasmodium falciparum Intra-Erythrocytic Cycle and Drives Drug Transporter Genes Expression
Maria Isabel Veiga et al.
PLOS ONE (2010)
Chloroquine Clinical Failures in P. falciparum Malaria Are Associated with Mutant Pfmdr-1, Not Pfcrt in Madagascar
Valerie Andriantsoanirina et al.
PLOS ONE (2010)
In Vitro Activities of Piperaquine, Lumefantrine, and Dihydroartemisinin in Kenyan Plasmodium falciparum Isolates and Polymorphisms in pfcrt and pfmdr1
Leah Mwai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Role of Known Molecular Markers of Resistance in the Antimalarial Potency of Piperaquine and Dihydroartemisinin In Vitro
Sant Muangnoicharoen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Multidrug Resistance Through the Spectacle of P-Glycoprotein
Katalin Goda et al.
CURRENT CANCER DRUG TARGETS (2009)
In Vivo Selection of Plasmodium falciparum Parasites Carrying the Chloroquine-Susceptible pfcrt K76 Allele after Treatment with Artemether-Lumefantrine in Africa
Christin Sisowath et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Membrane transport proteins of the malaria parasite
Rowena E. Martin et al.
MOLECULAR MICROBIOLOGY (2009)
Artemisinin Resistance in Plasmodium falciparum Malaria.
Arjen M. Dondorp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine
Juliana Martha Sa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasion
Karen Hayton et al.
CELL HOST & MICROBE (2008)
Evidence of Artemisinin-Resistant Malaria in Western Cambodia
Harald Noedl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A Genetically Hard-Wired Metabolic Transcriptome in Plasmodium falciparum Fails to Mount Protective Responses to Lethal Antifolates
Karthikeyan Ganesan et al.
PLOS PATHOGENS (2008)
Flexibility in the ABC transporter MsbA: Alternating access with a twist
Andrew Ward et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Plasmodium falciparum:: Genome wide perturbations in transcript profiles among mixed stage cultures after chloroquine treatment
Anusha M. Gunasekera et al.
EXPERIMENTAL PARASITOLOGY (2007)
Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa
Gabrielle Holmgren et al.
INFECTION GENETICS AND EVOLUTION (2007)
Artesunate-amodiaquine for the treatment of uncomplicated malaria
Sodiomon Bienvenu Sirima et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Activity of piperaquine and other 4-aminoquinoline antiplasmodial drugs against chloroquine -sensitive and resistant blood-stages of Plasmodium falciparum -: Role of β-haematin inhibition and drug concentration in vacuolar water- and lipid-phases
David C. Warhurst et al.
BIOCHEMICAL PHARMACOLOGY (2007)
The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa
Christin Sisowath et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2007)
Recurrent gene amplification and soft selective sweeps during evolution of multidrug resistance in malaria parasites
Shalini Nair et al.
MOLECULAR BIOLOGY AND EVOLUTION (2007)
Intrahost selection of Plasmodium falciparum pfmdr1 alleles after antimalarial treatment on the northwestern border of Thailand
Anne-Catrin Uhlemann et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria
G. S. Humphreys et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Amodiaquine resistance is not related to rare findings of pfmdr1 gene amplifications in Kenya
Gabrielle Holmgren et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2006)
Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin
Amar Bir Singh Sidhu et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum
Petra Rohrbach et al.
EMBO JOURNAL (2006)
Role of US military research programs in the development of US Food and Drug Administration - Approved antimalarial drugs
LW Kitchen et al.
CLINICAL INFECTIOUS DISEASES (2006)
Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y
G Holmgren et al.
INFECTION GENETICS AND EVOLUTION (2006)
Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria
RN Price et al.
CLINICAL INFECTIOUS DISEASES (2006)
Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic
C Dokomajilar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
No pfmdr1 amplifications in samples from Guinea-Bissau and Liberia collected between 1981 and 2004
Johan Ursing et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon
AC Uhlemann et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum
ABS Sidhu et al.
MOLECULAR MICROBIOLOGY (2005)
Contribution of the pfmdr1 gene to antimalarial drug-resistance
MT Duraisingh et al.
ACTA TROPICA (2005)
In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem)
C Sisowath et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
pfmdr1 mutations associated with chloroquine resistance incur a fitness cost in Plasmodium falciparum
R Hayward et al.
MOLECULAR MICROBIOLOGY (2005)
The 'permeome' of the malaria parasite: an overview of the membrane transport proteins of Plasmodium falciparum
RE Martin et al.
GENOME BIOLOGY (2005)
Piperaquine - A resurgent antimalarial drug
TME Davis et al.
DRUGS (2005)
CV8, a new combination of dihydroartemisinin, piperaquine, trimethoprim and primaquine, compared with atovaquone-proguanil against falciparum malaria in Vietnam
PT Giao et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2004)
Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam:: randomised clinical trial
TT Hien et al.
LANCET (2004)
Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number
RN Price et al.
LANCET (2004)
The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum
Z Bozdech et al.
PLOS BIOLOGY (2003)
Resistance to antimalarials in southeast Asia and genetic polymorphisms in pfmdr1
AL Pickard et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Mapping of the Plasmodium falciparum multidrug resistance gene 5′-upstream region, and evidence of induction of transcript levels by antimalarial drugs in chloroquine sensitive parasites
A Myrick et al.
MOLECULAR MICROBIOLOGY (2003)
Drug-induced alterations in gene expression of the asexual blood forms of Plasmodium falciparum
AM Gunasekera et al.
MOLECULAR MICROBIOLOGY (2003)
Molecular epidemiology of malaria in Cameroon.: IX.: Characteristics of recrudescent and persistent Plasmodium falciparum infections after chloroquine or amodiaquine treatment in children
LK Basco et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2002)
Pfmdr1 alleles and response to ultralow-dose mefloquine treatment in gabonese patients
DP Mawili-Mboumba et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
High-level chloroquine resistance in sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance gene pfmdr1
HA Babiker et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
A molecular marker for chloroquine-resistant falciparum malaria
A Djimdé et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Mutations in the P-falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance
DA Fidock et al.
MOLECULAR CELL (2000)
Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site
M Korsinczky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand:: a prospective study
F Nosten et al.
LANCET (2000)
Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum
MT Duraisingh et al.
MOLECULAR MICROBIOLOGY (2000)
Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum
MB Reed et al.
NATURE (2000)
The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin
MT Duraisingh et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2000)
分享论文
